These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8484979)

  • 1. Oral tegafur in the treatment of metastatic breast cancer: a phase II study.
    Kajanti MJ; Pyrhönen SO; Maiche AG
    Eur J Cancer; 1993; 29A(6):863-6. PubMed ID: 8484979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer.
    Solé LA; Albanell J; Bellmunt J; Ribas A; Gallego OS; Carulla J
    Cancer; 1995 Feb; 75(3):831-5. PubMed ID: 7828134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy].
    Ogawa Y; Ishikawa T; Ogisawa K; Ikeda K; Nagatsuka I; Matsumura Y; Takashima T; Yashiro M; Onoda N; Nakata B; Kato Y; Hirakawa K
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2123-7. PubMed ID: 11103246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institution.
    Hara F; Kiyoto S; Takahashi M; Takabatake D; Takashima S; Aogi K; Ohsumi S; Takashima S
    Oncology; 2010; 79(3-4):273-7. PubMed ID: 21372603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
    Onyenadum A; Gogas H; Markopoulos C; Bafaloukos D; Aravantinos G; Mantzourani M; Koutras A; Tzorakoelefterakis E; Xiros N; Makatsoris T; Fountzilas G; Kalofonos HP
    J Chemother; 2007 Oct; 19(5):582-9. PubMed ID: 18073159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine.
    Ito Y; Osaki Y; Tokudome N; Sugihara T; Takahashi S; Iwase T; Hatake K
    Breast Cancer; 2009; 16(2):126-31. PubMed ID: 18807123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical results of UFT granule of enteric coating (UFT E granule). Osaka UFT E Granule Study Group].
    Taguchi T
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1295-301. PubMed ID: 2114825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A patient with pulmonary metastasis from breast cancer after surgery who responded to S-1].
    Yoneyama K; Yamada A; Koshida Y; Toriumi F; Murayama T; Toeda H; Imazu Y; Motegi K; Akamatsu H; Ooyama R
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1143-6. PubMed ID: 17637559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
    Watanabe O; Shimizu T; Imamura H; Kinoshita J; Okabe T; Ogawa K; Haga S
    Gan To Kagaku Ryoho; 2004 May; 31(5):717-21. PubMed ID: 15170979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer.
    Klaassen U; Borquez D; Lang S; Oberhoff C; Harstrick A; Seeber S; Benner S
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):71-3. PubMed ID: 10442367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of S-1 in pretreated metastatic breast cancer patients.
    Shien T; Shimizu C; Akashi-Tanaka S; Yonemori K; Kohno T; Hojo T; Ando M; Katsumata N; Kinoshita T; Fujiwara Y
    Jpn J Clin Oncol; 2008 Mar; 38(3):172-5. PubMed ID: 18296424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.
    Ueno H; Okada S; Okusaka T; Ikeda M; Kuriyama H
    Oncology; 2002; 62(3):223-7. PubMed ID: 12065869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UFT/oral calcium folinate plus weekly paclitaxel for metastatic breast cancer.
    Lück HJ; Scholz U; Kühnle H; Dethling J
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):74-6. PubMed ID: 10442368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience.
    Lin JK; Wang WS; Hsieh RK; Hsu TC; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Jpn J Clin Oncol; 2000 Nov; 30(11):510-4. PubMed ID: 11155922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of CI-973 [SP-4-3(R)]-1,1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N') platinum in patients with refractory advanced breast cancer.
    Theriault RL; Walters RS; Holmes FA; Esparza-Guerra L; Kowal C; Hortobagyi GN
    Cancer Chemother Pharmacol; 1996; 38(3):289-91. PubMed ID: 8646805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trial of UFT against disseminated breast cancer].
    Itoh S; Konishi Y; Harauchi D; Shinoto M
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2381-5. PubMed ID: 6437344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical benefit of S-1 in metastatic breast cancer].
    Saeki T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():202-6. PubMed ID: 16898003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.
    Robert NJ; Conkling PR; O'Rourke MA; Kuefler PR; McIntyre KJ; Zhan F; Asmar L; Wang Y; Shonukan OO; O'Shaughnessy JA
    Breast Cancer Res Treat; 2011 Feb; 126(1):101-8. PubMed ID: 21188632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of carboplatin and etoposide in metastatic breast cancer.
    Crown J; Hakes T; Reichman B; Lebwohl D; Gilewski T; Surbone A; Currie V; Yao TJ; Hudis C; Seidman A
    Cancer; 1993 Feb; 71(4):1254-7. PubMed ID: 8435802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.